Explore research-focused peptide articles designed to make complex compounds, safety considerations, and emerging peptide science easier to understand.
AIC (AICAR): What the Research Actually Shows in 2026 Type "aic" into a search bar and the internet splits three ways. You might want Alice in Chains. You might want American International College scores. Or you might have landed on a gray-market vial of AICA…
CJC-1295 and Ipamorelin: Why Researchers Pair These Peptides Reading Time: 8 mins This article is for general education only and does not replace medical advice from a licensed healthcare professional. The Short Answer CJC-1295 (a GHRH analogue) and Ipamoreli…
Glutathione Benefits in Research: Why It's Studied for Oxidative Stress and Cellular Health Most of what you've heard about glutathione depends on which world you're standing in. In biochemistry, it's the most abundant antioxidant your cells make — a molecule…
5 Amino 1MQ: Research Guide, Benefits, and How It Works Search for "5 amino 1mq benefits" and you'll find plenty of confident answers: rapid fat loss, more energy, a faster metabolism, muscle support for aging. What those pages almost never mention: not one o…
Tirzepatide Side Effects in Research: What to Track Nobody searches for a drug's mechanism of action at 1 a.m. They search tirzepatide side effects — because something already happened. Nausea after the first shot. Three days of constipation. A Reddit thread …
Semaglutide vs Tirzepatide vs Retatrutide: What's the Difference? By the Generic Peptides Team One, two, three hormones — and why the scale drops further with each new drug. Ten years ago, the phrase "a pill that makes you lose weight" sounded like a promise …
Glutathione (γ-Glu-Cys-Gly): Liposomal Oral Delivery, a Negative Parkinson's Meta-Analysis, and the 2024 Philippines DOH Warning Against IV Skin-Lightening Drips By Medical Team of Generic Peptides Glutathione (GSH) is an endogenous tripeptide composed of thr…
NAD+ (Nicotinamide Adenine Dinucleotide): The Endogenous Coenzyme With Established Biochemical Effects, FDA-Resolved NMN Regulatory Status as of September 2025, and Inconclusive Clinical Outcomes Evidence Despite Wellness Industry Marketing By Medical Team of…
5-Amino-1MQ (5-Amino-1-Methylquinolinium): The Investigational Small-Molecule NNMT Inhibitor With Preclinical Anti-Obesity Evidence and No Confirmed Human Clinical Trials Despite Widespread Marketing Claims By Medical Team of Generic Peptides 5-Amino-1MQ is a…
Retatrutide (LY3437943): The Investigational First-in-Class Triple GIP/GLP-1/Glucagon Receptor Agonist With 28.7% Weight Loss in Phase 3 TRIUMPH-4 and the Dysesthesia Signal Defining Its Safety Profile By Medical Team of Generic Peptides Retatrutide (LY343794…
Tirzepatide (Mounjaro / Zepbound): The First-in-Class Dual GIP/GLP-1 Receptor Agonist With FDA-Approved T2DM, Obesity, and Sleep Apnea Indications and Superior Weight Loss to Semaglutide in 2025 SURMOUNT-5 By Medical Team of Generic Peptides Tirzepatide (LY32…
Thymosin Alpha-1 (Thymalfasin / Zadaxin): The 28-Amino-Acid Synthetic Thymic Peptide With 35+ Country Approval, Definitive 2025 Phase III Sepsis Trial Failure, and Complicated December 2024 PCAC Negative Vote By Medical Team of Generic Peptides Thymosin Alpha…